Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.
Experts see shift toward tailored cancer therapy model Lilly awaiting details of Novo's failed trial Some drug developers target multiple biomarkers Sign up here. Globally, over 55 million people have ...
One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, according to a new study published November 5, 2025, in npj Precision Oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results